|
Rank
|
Status
|
Study
|
|
1
|
Suspended
|
Stromal Gene Expression During Pulmonary Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
|
|
|
2
|
Active, not recruiting
|
The Efficacy and Safety of CC-10004 in Chronic Cutaneous
Sarcoidosis
|
Conditions:
|
Sarcoidosis; Cutaneous Sarcoidosis
|
|
Intervention:
|
Drug: CC-100004
|
|
|
3
|
Terminated
|
Trial of Adalimumab in Progressive Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: Adalimumab
|
|
|
4
|
Recruiting
|
Sarcoidosis With Cardiac Involvement and FDG-PET
|
Conditions:
|
Sarcoidosis; Dilated Cardiomyopathy
|
|
Intervention:
|
|
|
|
5
|
Completed
|
Identifying Shared Genetic Susceptibility Regions in Chronic
Beryllium Disease and Sarcoidosis
|
Conditions:
|
Sarcoidosis; Berylliosis
|
|
Intervention:
|
|
|
|
6
|
Active, not recruiting
|
Use of Armodafinil for Fatigue in Sarcoidosis
|
Conditions:
|
Sarcoidosis; Fatigue; Sleepiness
|
|
Interventions:
|
Drug: Armodafinil; Drug: Placebo
|
|
|
7
|
Active, not recruiting
|
Trial of Antimycobacterial Therapy in Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Interventions:
|
Drug: antibiotics; Drug: lactose
|
|
|
8
|
Recruiting
|
Role of Proteomics in Diagnosing Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
|
|
|
9
|
Completed
|
Rickettsial Genesis to Sarcoidosis in Denmark
|
Conditions:
|
Sarcoidosis; Rickettsia Infections
|
|
Intervention:
|
|
|
|
10
|
Completed
|
Investigation of the Efficacy of Antibiotics on Pulmonary
Sarcoidosis
|
Conditions:
|
Pulmonary Sarcoidosis; Lung Function
|
|
Intervention:
|
Drug: levaquin; ethambutol; rifampin
and azithromycin.
|
|
|
11
|
Completed
|
Exercise Training in Sarcoidosis (EXTRAS Study)
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Behavioral: High-intensity exercise
training
|
|
|
12
|
Unknown †
|
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary
Hypertension
|
Conditions:
|
Sarcoidosis; Pulmonary Hypertension
|
|
Intervention:
|
Drug: Ambrisentan
|
|
|
13
|
Completed
|
Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis
|
Conditions:
|
Sarcoidosis; Mediastinal Diseases
|
|
Intervention:
|
Procedure: Bronchoscopy
|
|
|
14
|
Not yet recruiting
|
Cardiac Sarcoidosis Response To Steroids Trial
|
Conditions:
|
Cardiac Sarcoidosis; Sarcoidosis
|
|
Intervention:
|
Drug: Prednisone
|
|
|
15
|
Completed
|
Antibody Response to Influenza Vaccine in Patients With
Sarcoidosis
|
Condition:
|
Pulmonary Sarcoidosis
|
|
Intervention:
|
Biological: Influenza Vaccine
|
|
|
16
|
Recruiting
|
Trial for the Diagnosis of Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Interventions:
|
Procedure: EUS-FNA/EBUS-TBNA + BAL; Procedure: EBB + TBLB + BAL
|
|
|
17
|
Completed
|
Muscle Strength and Exercise Capacity in Sarcoidosis Patients
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
|
|
|
18
|
Enrolling by invitation
|
Implantable Cardiac Defibrillators for the Prevention of
Sudden Death in Patients With Cardiac Sarcoidosis
|
Conditions:
|
Sarcoidosis of the Heart; Cardiomyopathy
|
|
Intervention:
|
|
|
|
19
|
Completed
|
Eye and Immunogenetic Features of Sarcoidosis
|
Conditions:
|
Sarcoidosis; Uveitis
|
|
Intervention:
|
|
|
|
20
|
Recruiting
|
Rituximab as a Novel Therapy in Refractory Sarcoidosis:
A Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: Rituximab
|
|
|
21
|
Recruiting
|
Atorvastatin
to Treat Pulmonary Sarcoidosis
|
Condition:
|
Sarcoidosis, Pulmonary
|
|
Intervention:
|
Drug: Atorvastatin
|
|
|
22
|
Completed
|
Study of Eye
Tissue for Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
|
|
|
23
|
Enrolling by invitation
|
The
Influence of Personality on Pulmonary Fibrosis and Sarcoidosis
|
Conditions:
|
Sarcoidosis; Pulmonary Fibrosis
|
|
Intervention:
|
|
|
|
24
|
Terminated
|
Safety
and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis
|
Conditions:
|
Sarcoidosis; Pulmonary Hypertension
|
|
Interventions:
|
Drug: bosentan; Drug: placebo
|
|
|
25
|
Completed
|
Diagnostic
Yield of Vitreous Biopsy in Sarcoid Uveitis
|
Condition:
|
Sarcoidosis-Associated Ocular Inflammation
|
|
Intervention:
|
Procedure: Diagnostic Vitrectomy
|
|
|
26
|
Completed
|
The Effect
of Quercetin in Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Interventions:
|
Dietary Supplement: quercetin; Other: placebo
|
|
|
27
|
Recruiting
|
A
Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered
Subcutaneously (SC) in Patients With Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Interventions:
|
Drug: Placebo; Drug: ustekinumab; Drug: golimumab
|
|
|
28
|
Completed
|
SARCOTHAL.
Thalidomide in Skin Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: THALIDOMIDE
|
|
|
29
|
Completed
|
Use
of Focalin for Fatigue in Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: d-methylphenidate
|
|
|
30
|
Recruiting
|
Efficacy
of Antituberculous Therapy in Management of Sarcoidosis
|
Conditions:
|
Sarcoidosis; Tuberculosis
|
|
Intervention:
|
Drug: Antituberculous therapy along
with steroids
|
|
|
31
|
Completed
|
Treatment
of Pulmonary Sarcoidosis With Pentoxifylline
|
Condition:
|
Pulmonary Sarcoidosis
|
|
Intervention:
|
Drug: Pentoxifylline
|
|
|
32
|
Completed
|
Inhaled
Iloprost for Sarcoidosis-associated Pulmonary Hypertension
|
Conditions:
|
Sarcoidosis; Pulmonary Arterial Hypertension
|
|
Intervention:
|
Drug: Iloprost
|
|
|
33
|
Withdrawn
|
Efficacy
Study of Humira in the Treatment of Cutaneous Sarcoidosis
|
Conditions:
|
Sarcoidosis; Cutaneous Sarcoidosis
|
|
Intervention:
|
Drug: Humira
|
|
|
34
|
Suspended
|
Study
of Nicotine Patches in Patients With Sarcoidosis
|
Condition:
|
Pulmonary Sarcoidosis
|
|
Intervention:
|
Drug: nicotine patch
|
|
|
35
|
Recruiting
|
Double
Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
|
Conditions:
|
Sarcoidosis; Pulmonary Arterial Hypertension
|
|
Interventions:
|
Drug: Bosentan; Drug: Placebo
|
|
|
36
|
Recruiting
|
Tadalafil
for Sarcoidosis Associated Pulmonary Hypertension
|
Condition:
|
Pulmonary Hypertension
|
|
Intervention:
|
Drug: Tadalafil
|
|
|
37
|
Recruiting
|
A
Study of Adalimumab to Treat Sarcoidosis of the Skin
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: adalimumab
|
|
|
38
|
Completed
|
A
Study of Infliximab in Patients With Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: Infliximab
|
|
|
39
|
Terminated
|
Safety
Study of Abatacept to Treat Refractory Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: Abatacept
|
|
|
40
|
Withdrawn
|
A
Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: Rituximab
|
|
|
41
|
Terminated
|
Mycophenolate
for Pulmonary Sarcoidosis
|
Condition:
|
Pulmonary Sarcoidosis
|
|
Intervention:
|
Drug: Mycophenolate
|
|
|
42
|
Completed
|
Minimally
Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Procedure: Bronchoscopy
|
|
|
43
|
Recruiting
|
Hematopoietic
Stem Cell Support in Patients With Refractory Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Procedure: Hematopoietic stem cell
transplantation
|
|
|
44
|
Completed
|
Pathogen
Specific Immunity in Patients With Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Procedure: Bronchoalveolar Lavage
and Venipuncture
|
|
|
45
|
Not yet recruiting
|
Rehabilitation
in Pulmonary Sarcoidosis: a Prospective Study
|
Condition:
|
Pulmonary Sarcoidosis
|
|
Intervention:
|
|
|
|
46
|
Recruiting
|
Efficacy
Study of Methotrexate to Treat Sarcoid-associated Uveitis
|
Conditions:
|
Sarcoid-associated Uveitis; Ocular Sarcoidosis; Macular Edema
|
|
Interventions:
|
Drug: Methotrexate; Drug: Placebo
|
|
|
47
|
Withdrawn
|
Study
to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
Drug: adalimumab
|
|
|
48
|
Terminated
|
Study
of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies:
IV Infusion QOD x Six Doses
|
Condition:
|
Neoplasms
|
|
Intervention:
|
Drug: SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin
Immunotoxin
|
|
|
49
|
Recruiting
|
SS1P
and Pentostatin Plus Cyclophosphamide for Mesothelioma
|
Condition:
|
Mesothelioma
|
|
Interventions:
|
Drug: Pentostatin; Drug: Cyclophosphamide; Drug: SS1P
|
|
|
50
|
Terminated
|
Study
of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies:
Continuous Infusion for 10 Days
|
Condition:
|
Neoplasms
|
|
Intervention:
|
Drug: SS1(dsFv)-PE38
|
|
|
51
|
Completed
|
Sarcoidosis-associated
Pulmonary Hypertension
|
Condition:
|
SARCOIDOSIS
|
|
Intervention:
|
|
|
|
52
|
Recruiting
|
A
Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab
in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
|
Conditions:
|
Non-Small Cell Lung Cancer; Adenocarcinoma
|
|
Interventions:
|
Drug: SS1 (dsFv) PE38; Drug: Paclitaxel; Drug: Carboplatin; Drug: Bevacizumab
|
|
|
53
|
Completed
|
The
Occurence of Inflammation and Oxidative Stress in Lung Diseases
|
Conditions:
|
Interstitial Lung Diseases; Sarcoidosis; Idiopathic Pulmonary Fibrosis; COPD
|
|
Intervention:
|
|
|
|
54
|
Completed
|
Genetic Epidemiology
of Sarcoidosis
|
Conditions:
|
Lung Diseases; Sarcoidosis
|
|
Intervention:
|
|
|
|
55
|
Completed
|
A
Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
|
Conditions:
|
Lung Diseases; Sarcoidosis
|
|
Intervention:
|
|
|
|
56
|
Completed
|
Sarcoid Genetic
Analysis (SAGA)
|
Conditions:
|
Lung Diseases; Sarcoidosis
|
|
Intervention:
|
|
|
|
57
|
Completed
|
Salivary
Proteins in Disease and Health
|
Conditions:
|
Diabetes Mellitus; Sarcoidosis; Dental Caries; Sjorgren's Syndrome; Cystinosis; Head and Neck Neoplasms
|
|
Intervention:
|
|
|
|
58
|
Completed
|
Diagnostic
Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in
Sarcoidosis Patient
|
Condition:
|
Sarcoidosis
|
|
Intervention:
|
|
|
|
59
|
Unknown †
|
Immunotoxin
Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural
Mesothelioma That Cannot Be Removed by Surgery
|
Condition:
|
Malignant Mesothelioma
|
|
Interventions:
|
Biological: SS1(dsFv)-PE38 immunotoxin; Drug: cisplatin; Drug: pemetrexed disodium; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: pharmacological study; Procedure: quality-of-life assessment
|
|
|
60
|
Recruiting
|
A
Study of the Natural Progression of Interstitial Lung Disease (ILD)
|
Conditions:
|
Interstitial Lung Diseases; Idiopathic Pulmonary Fibrosis; Sarcoidosis
|
|
Intervention:
|
|
|
|
61
|
Withdrawn
|
CryoSpray
Ablation(tm)Thoracic Patient Registry
|
Conditions:
|
Lung Cancer; Emphysema; Chronic Bronchitis; COPD;
Asthma; Sarcoidosis; Mesothelioma
|
|
Intervention:
|
|
|
|
62
|
Not yet recruiting
|
Diagnosis
of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)
|
Conditions:
|
Lung Disease, Chronic Obstructive; Lung Disease, Interstitial; Asthma;
Sarcoidosis; Hypertension, Pulmonary
|
|
Intervention:
|
|
|
|
63
|
Recruiting
|
Phase
2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
|
Conditions:
|
Emphysema; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Pulmonary Fibrosis; Bronchiectasis; Sarcoidosis; Pulmonary Hypertension; Alpha-1 Antitrypsin Deficiency
|
|
Intervention:
|
Procedure: Transplantation of Lungs
After Ex-vivo Perfusion w/ STEEN Solution™
|
|
|
64
|
Unknown †
|
A
Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY
(REMEDY)
|
Conditions:
|
Isolated Mediastinal Lymphadenopathy; Sarcoidosis; Tuberculosis; Lung Cancer; Lymphoma
|
|
Intervention:
|
Procedure: EBUS
|
|
|
65
|
Terminated
|
Interventional
Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
|
Conditions:
|
Benign Airway Disease; Sarcoidosis; Wegener's Granulomatosis; Rhinoscleroma; Recurrent Respiratory Papillomatosis(RRP)
|
|
Intervention:
|
Device: CryoSpray Ablation (tm)
|
|
|
66
|
Completed
|
Diffuse Fibrotic
Lung Disease
|
Conditions:
|
Lung Diseases; Pulmonary Fibrosis; Sarcoidosis
|
|
Interventions:
|
Drug: prednisone; Drug: cyclophosphamide; Drug: dapsone
|
|
|
67
|
Recruiting
|
Role
of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
|
Conditions:
|
Pulmonary Disease; Oropharyngeal Disease; Lymphangioleiomyomatosis; Pulmonary Fibrosis; Asthma;
Sarcoidosis
|
|
Intervention:
|
|
|
|
68
|
Completed
|
Immunotoxin
Therapy in Treating Patients With Advanced Cancer
|
Conditions:
|
Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Primary Peritoneal Cavity Cancer
|
|
Intervention:
|
Biological: SS1(dsFv)-PE38 immunotoxin
|
|
|
69
|
Completed
|
Immunotoxin
Therapy, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced
Non-Small Cell Lung Cancer
|
Condition:
|
Lung Cancer
|
|
Interventions:
|
Biological: SS1(dsFv)-PE38 immunotoxin; Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: laboratory biomarker analysis; Other: pharmacological study
|
|
|
70
|
Completed
|
Immunotoxin
Therapy in Treating Patients With Advanced Solid Tumors
|
Conditions:
|
Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Primary Peritoneal Cavity Cancer
|
|
Intervention:
|
Biological: SS1(dsFv)-PE38 immunotoxin
|
|
|
71
|
Unknown †
|
Uveitis Gene-Expression
Profiling
|
Condition:
|
Uveitis
|
|
Intervention:
|
|
|
|
72
|
Completed
|
Individual
Sensitivity for Interstitial Lung Diseases
|
Condition:
|
Interstitial Lung Diseases
|
|
Intervention:
|
|
|
|
73
|
Completed
|
Rapid
On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
|
Conditions:
|
Lung Cancer; Sarcoidosis; Tuberculosis
|
|
Interventions:
|
Procedure: Rapid on-site cytopathologic
evaluation (ROSE); Procedure: TBNA
|
|
|
74
|
Recruiting
|
Role
of Genetic Factors in the Development of Lung Disease
|
Conditions:
|
Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
|
|
Intervention:
|
|
|
|
75
|
Completed
|
Immunological
Characterization of Bronchoalveolar Cells in Normals
|
Condition:
|
Lung Disease
|
|
Intervention:
|
|
|
|
76
|
Recruiting
|
Linear
Endosonography for the Assessment of Sarcoidosis Stage O
|
Condition:
|
Lymphadenitis
|
|
Intervention:
|
Procedure: Thoracic endosonography
|
|
|
77
|
Unknown †
|
Database
of Interstitial Lung Diseases
|
Condition:
|
Interstitial Lung Diseases
|
|
Intervention:
|
|
|
|
78
|
Terminated
|
Use of Thalidomide
in Chronic Uveitis
|
Condition:
|
Uveitis
|
|
Intervention:
|
Drug: Thalidomide
|
|
|
79
|
Completed
|
Evaluation
and Treatment of Patients With Inflammatory Eye Diseases
|
Conditions:
|
Choroiditis; Iridocyclitis; Iritis;
Retinal Disease
|
|
Intervention:
|
|
|
|
80
|
Terminated
|
Evaluation
of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases
|
Condition:
|
Interstitial Lung Disease
|
|
Interventions:
|
Drug: INS316 solution for inhalation; Drug: hypertonic saline 3% sodium chloride
solution
|
|
|
81
|
Recruiting
|
Safety
and Efficacy of AIN457 in Noninfectious Uveitis
|
Condition:
|
Active Uveitis That is Not From an
Infection.
|
|
Interventions:
|
Drug: AIN457 subcutaneous dose; Drug: AIN457 low dose (i.v); Drug: AIN457 high dose (i.v)
|
|
|
82
|
Completed
|
Low
Salt Diet in Idiopathic Hypercalciuria
|
Condition:
|
Hypercalciuria
|
|
Interventions:
|
Behavioral: Low salt diet; Behavioral: Water therapy alone
|
|
|
83
|
Unknown †
|
Pulmonary
Rehabilitation in Interstitial Lung Disease
|
Condition:
|
Interstitial Lung Disease
|
|
Intervention:
|
Behavioral: Pulmonary Rehabilitation
|
|
|
84
|
Recruiting
|
Evaluation
and Follow-up of Patients With Cryptococcosis
|
Conditions:
|
Cryptococcosis; Lymphopenia
|
|
Intervention:
|
|
|
|
85
|
Recruiting
|
Safety
Evaluation of Dexmedetomidine for EBUS-TBNA
|
Condition:
|
Lung Cancer
|
|
Interventions:
|
Drug: Remifentanil; Drug: Dexmedetomidine
|
|
|
86
|
Terminated
|
Trial
to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
|
Conditions:
|
Coronary Artery Disease; Inflammatory Response; Atherosclerosis
|
|
Intervention:
|
Dietary Supplement: eicosapentaenoic
acid (EPA),
|
|
|
87
|
Completed
|
Study
to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities
of Chronic Obstructive Disease
|
Condition:
|
Chronic Obstructive Pulmonary Disease
|
|
Intervention:
|
|
|
|
88
|
Completed
|
Assessment
of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
|
Conditions:
|
Asthma; Hypersensitivity; Lung Diseases; Wegener's Granulomatosis
|
|
Intervention:
|
|
|
|
89
|
Not yet recruiting
|
A
Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma
|
Condition:
|
Exercise Induced Asthma
|
|
Intervention:
|
|
|
|
90
|
Recruiting
|
Breath
Analysis by Ion Mobility Spectrometry
|
Condition:
|
Lung Diseases
|
|
Intervention:
|
|
|
|
91
|
Not yet recruiting
|
Volatile
Organic Compounds (VOCs) and Liver Diseases
|
Condition:
|
Liver Diseases
|
|
Intervention:
|
|
|
|
92
|
Recruiting
|
Breath
Test for Early Detection of Lung Cancer
|
Condition:
|
Lung Neoplasms
|
|
Intervention:
|
|
|
|
93
|
Completed
|
Sensitivity
and Specificity of the Home Macular Perimeter (HMP)
|
Condition:
|
Age Related Macular Degeneration
|
|
Intervention:
|
|
|
|
94
|
Completed
|
CARDS
Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics
Without CV Disease Reduces The Risk Of CV Events
|
Conditions:
|
Major Coronary Event; Cerebrovascular Accident; Coronary Artery Bypass Graft; Angina, Unstable; Revascularization
|
|
Intervention:
|
Drug: Atorvastatin
|
|
